In this context, we have demonstrated that persistent subclinical exposure to PG-LPS induces myocardial cell damage and heart failure with the activation of cyclic AMP (cAMP)-protein kinase A (PKA) and Ca2+/calmodulin-dependent protein kinase II (CaMKII) signaling [18]. Here, CAMK2G is linked to heart failure.